LHRH Antagonists Restore Serum Testosterone Faster Than LHRH Agonists in Prostate Cancer Patients After Radiotherapy
LHRH antagonists restored serum TST to castration and therapeutic levels faster than LHRH agonists in prostate cancer patients undergoing radiation therapy with ADT.
Authors
- Koichiro Akakura (ORCID: https://orcid.org/0000-0003-4368-1574)
- Shinichi Sakamoto (ORCID: https://orcid.org/0000-0002-7508-7521)
- Tomohiko Kamasako
- Tomokazu Sazuka (ORCID: https://orcid.org/0000-0002-8902-7853)
- Tomohiko Ichikawa (ORCID: https://orcid.org/0000-0002-8637-4163)
- Sangjon Pae
- Tomohiro Tamura (ORCID: https://orcid.org/0000-0003-2409-6556)
- Yusuke Imamura (ORCID: https://orcid.org/0009-0006-7207-1520)
- Yasutaka Yamada (ORCID: https://orcid.org/0000-0002-0070-1590)
- Xue Zhao
- Akinori Takei
Institutions
- Chiba University (JP)
- Matsudo City Hospital (JP)
- Shizuoka General Hospital (JP)
Publication Details
- Journal
- The Prostate
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1002/pros.24899
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Astellas Pharma
- Astellas Foundation for Research on Metabolic Disorders
- Japan Society for the Promotion of Science